CAMH....worth watching

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • grebnet
    replied
    Camh

    Jim....I have always respected your posts and picks . My statements are not meant to insult you ...just posting my concerns .


    I welcome your explanation.

    Leave a comment:


  • Jim Smith
    Guest replied
    Grebnet, you just don't understand

    and I don't think your Cardio knows either....anyway, you'r out and it's flying.

    Leave a comment:


  • grebnet
    replied
    Not sure what you mean ??????

    Originally posted by Jim Smith View Post
    Grebnet, you don't sound like a senior member.....
    Do you just not like a negative sentiment ???

    I have ( until Friday ) owned 1.8 blocks(per haddad)from 4/20/06,4/24,and 7/11/06 . My negative came about after speaking with a cardiologist friend ( while he was inserting a defribillating pacemaker )
    he felt this alterans test was of no value... He may be 100 % wrong but to me there are plenty of other stocks out there. It wont bother me if you all make more $$$ in this than I did and I wish you well.

    Its better to sell and be sorry than to not sell and be sorry..

    Leave a comment:


  • riverbabe
    replied
    Originally posted by Jim Smith View Post
    New CEO is sales and marketing oriented..........the sales force is now just starting to ramp
    So, from 2-3 sales persons to how many? Never could figure out why they just didn't hire a company with a strong sales force, like Henry Schein or J&J or Abbott, to do the sales and marketing for them. Or maybe that's what the new CEO has in mind? river

    Leave a comment:


  • Jim Smith
    Guest replied
    CAMH is rocking

    Grebnet, you don't sound like a senior member.....

    Leave a comment:


  • grebnet
    replied
    Camh

    Just a note......I sold all of my CAMH yesterday after speaking with a cardiologist who said this T-wave alterans test is of no value. I was fairly high on its potential but decided they are earning so little money 2 million/qtr) that if his opinion is shared by other cardiologists...they are in trouble. Now that Im out it will probably go to $5 but thats OK I made a few $$$ on the deal and on to the next....

    Leave a comment:


  • Jim Smith
    Guest replied
    CAMH has strong potential

    Biolase makes water lasers for dentists....Their product costs up to $70K...Of course, dentists don't have to buy it and no government entity was reimbursing for use of it....BLTI ran to $22+ before imploding to $7....Now, CAMH makes a $30K device, the tests cost $400 per patient which the governement and many HMOs are willing to reimburse....MTWA, which CAMH machines measure, is the indicator for who needs an implantable cardiac defribillator....For years, MDT, STJ and BSX wanted to implant ICDs in everyone but now everyone is afraid, though some do need them....CAMH's technology is a risk stratifier for identifying who is at risk from sudden cardiac death and hence needs an ICD. In recent weeks, CAMH has taken steps to go from an R&D oriented company to a sales and markeing company with a new CEO and the nucleus of a sales force. Watch for ICD makers to embrace CAMH where before they saw them as a threat to their ICD market. This is what the ABCD test results, coming Nov 15th, will facilitate. Goldman sachs took this company public 10 years ago and it ran to $15.50 before tumbling....I believe it gets back and if sales continue to ramp, it gets there fast.

    Leave a comment:


  • New-born baby
    replied
    Originally posted by Jim Smith View Post
    this stock is worth watching....I believe this will be another Biolase Technology, the left side of the chart before the tumble.

    Jim,
    What is BIOLASE Technology? And what are your price targets for CAMH?

    Leave a comment:


  • mrmarket
    replied
    Jim...who let you out of your thread??

    Leave a comment:


  • Jim Smith
    Guest started a topic CAMH....worth watching

    CAMH....worth watching

    this stock is worth watching....November 2nd, the company announced a 121% YOY sales increase.....November 7th, the ceo will appear at a healthcare conference....November 15th we get the ABCD study results....New CEO is sales and marketing oriented.....Breakout of double peak at $2.60 ushered in move to nearly $3.....$3.11 is resistance .....THey've got the patents and the government is willing to pay for their product.....the sales force is now just starting to ramp....I believe this will be another Biolase Technology, the left side of the chart before the tumble.
Working...
X